|
92
|
286
|
5mqvA |
Crystal structure of human casein kinase i delta in complex with 4-(2,5-dimethoxyphenyl)-n-(4-(5-(4-fluorphenyl)-2-(methylthio)-1h-imidazol-4-yl)-pyridin-2-yl)-1-methyl-1h-pyrrole-2-carboxamide |
|
91
|
316
|
5kz8A |
Mark2 complex with 7-[(1s)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one |
|
95
|
492
|
5kq5A |
Ampk bound to allosteric activator |
|
86
|
316
|
5kz7A |
Mark2 complex with 7-[(1s)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one |
|
103
|
348
|
5kpmA |
Glycogen synthase kinase 3 beta complexed with brd3731 |
|
97
|
349
|
5kplA |
Glycogen synthase kinase 3 beta complexed with brd0705 |
|
95
|
350
|
5kpkA |
Glycogen synthase kinase 3 beta complexed with brd0209 |
|
98
|
347
|
5k5nA |
Crystal structure of gsk-3beta complexed with pf-04802367, a highly selective brain-penetrant kinase inhibitor |
|
97
|
292
|
5ih6A |
Human casein kinase 1 isoform delta (kinase domain) in complex with epiblastin a derivative |
|
96
|
293
|
5ih4A |
Human casein kinase 1 isoform delta apo (kinase domain) |
|
93
|
293
|
5ih5A |
Human casein kinase 1 isoform delta (kinase domain) in complex with epiblastin a |
|
103
|
351
|
5hlnA |
X-ray crystal structure of gsk3b in complex with chir99021 |
|
94
|
291
|
6gzmA |
Crystal structure of human ckidelta with a86 |
|
92
|
348
|
6gn1A |
Crystal structure of glycogen synthase kinase-3 beta (gsk3b) in complex with pik-75 |
|
101
|
493
|
6e4uA |
Structure of ampk bound to activator |
|
99
|
493
|
6e4tA |
Structure of ampk bound to activator |
|
96
|
493
|
6e4wA |
Structure of ampk bound to activator |
|
124
|
444
|
6c9dA |
Crystal structure of ka1-autoinhibited mark1 kinase |
|
99
|
348
|
6b8jA |
Co-structure of human glycogen synthase kinase beta with a selective (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine inhibitor |
|
100
|
352
|
6ae3A |
Crystal structure of gsk3beta complexed with morin |
|
97
|
291
|
5w4wA |
Identification and profiling of a selective and brain penetrant radioligand for in vivo target occupancy measurement of casein kinase 1 (ck1) inhibitors |
|
17
|
61
|
4f2lA |
Structure of a regulatory domain of ampk |
|
23
|
100
|
4eajA |
Co-crystal of ampk core with amp soaked with atp |
|
23
|
100
|
4eaiA |
Co-crystal structure of an ampk core with amp |
|
0
|
10
|
4ekkC |
Akt1 with amp-pnp |
|
21
|
99
|
4ealA |
Co-crystal of ampk core with atp soaked with amp |
|
21
|
99
|
4eakA |
Co-crystal structure of an ampk core with atp |
|
90
|
353
|
4ditA |
Crystal structure of gsk3beta in complex with a imidazopyridine inhibitor |
|
92
|
461
|
4cfhA |
Structure of an active form of mammalian ampk |
|
7
|
21
|
4cfhC |
Structure of an active form of mammalian ampk |
|
95
|
350
|
4b7tA |
Glycogen synthase kinase 3 beta complexed with axin peptide and leucettine l4 |
|
107
|
349
|
4afjA |
5-aryl-4-carboxamide-1,3-oxazoles: potent and selective gsk-3 inhibitors |
|
103
|
348
|
3zrmA |
Identification of 2-(4-pyridyl)thienopyridinones as gsk-3beta inhibitors |
|
98
|
350
|
4accA |
Gsk3b in complex with inhibitor |
|
104
|
349
|
3zrkA |
Identification of 2-(4-pyridyl)thienopyridinones as gsk-3beta inhibitors |
|
95
|
350
|
4achA |
Gsk3b in complex with inhibitor |
|
107
|
349
|
3zrlA |
Identification of 2-(4-pyridyl)thienopyridinones as gsk-3beta inhibitors |
|
94
|
350
|
4acgA |
Gsk3b in complex with inhibitor |
|
101
|
350
|
4acdA |
Gsk3b in complex with inhibitor |
|
99
|
349
|
3zdiA |
Glycogen synthase kinase 3 beta complexed with axin peptide and inhibitor 7d |
|
96
|
292
|
3uzpA |
Crystal structure of ck1d with pf670462 from p21 crystal form |
|
83
|
291
|
3uysA |
Crystal structure of apo human ck1d |
|
90
|
290
|
3uytA |
Crystal structure of ck1d with pf670462 from p1 crystal form |
|
107
|
350
|
3sd0A |
Identification of a glycogen synthase kinase-3b inhibitor that attenuates hyperactivity in clock mutant mice |
|
104
|
350
|
3sayA |
Crystal structure of human glycogen synthase kinase 3 beta (gsk3b) in complex with inhibitor 142 |
|
96
|
290
|
5x17A |
Crystal structure of murine ck1d in complex with adp |
|
97
|
493
|
5ufuA |
Structure of ampk bound to activator |
|
95
|
493
|
5t5tA |
Ampk bound to allosteric activator |
|
87
|
347
|
5t31A |
Exploiting an asp-glu switch in glycogen synthase kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia |
|
97
|
291
|
5oktA |
Crystal structure of human casein kinase i delta in complex with iwp-2 |
